The Use of High Resolution Chest Computed Tomography in Alpha-1 Antitrypsin Deficiency
NCT00532805 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 49
Last updated 2018-01-23
Summary
Individuals with a deficiency of alpha-1 antitrypsin (AAT) often develop emphysema. Traditional lung function tests may not be the most accurate way to measure the progression of emphysema. This study will compare high resolution computed tomography (CT) scans to spirometry to measure the progression of emphysema.
Conditions
- Alpha-1 Antitrypsin Deficiency
Sponsors & Collaborators
-
National Center for Research Resources (NCRR)
collaborator NIH -
Alpha-1 Foundation
collaborator OTHER -
Medical University of South Carolina
lead OTHER
Principal Investigators
-
Charlie Strange, MD · Medical University of South Carolina
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-08-31
- Primary Completion
- 2012-02-29
- Completion
- 2012-04-30
Countries
- United States
Study Locations
More Related Trials
-
Management of Patients With Alpha-1 Antitrypsin Deficiency Associated Emphysema
NCT00700934 ·Status: UNKNOWN
-
Hyperpolarized Xenon-129 MRI in Idiopathic Pulmonary Fibrosis
NCT06853145 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Correlation of Airflow Limitation and Other Respiratory Characteristics With Radiologic Changes of Lung Structure
NCT00799305 ·Status: UNKNOWN
-
Biomarkers and Genetic Factors Related to Emphysema
NCT00757120 ·Status: COMPLETED
-
Screening for Alpha-1 Antitrypsin Deficiency in Patients With Airway Obstruction
NCT07152834 ·Status: RECRUITING
-
Targeting Pulmonary Perfusion in Alpha-1 Antitrypsin Deficiency
NCT03008915 ·Status: COMPLETED ·Phase: PHASE2
-
Prevalence of Alpha-1 Antitrypsin Dysfunction in Pulmonary Emphysema
NCT02382367 ·Status: COMPLETED ·Phase: NA
-
Genomic Research in Alpha-1 Antitrypsin Deficiency
NCT01832220 ·Status: COMPLETED
-
Bronchiectasis Alpha-1 Augmentation Trial- Modulating Airway Neutrophil Function
NCT05582798 ·Status: COMPLETED ·Phase: PHASE4
-
129Xe Gas Exchange Imaging in IPF and cHP: A Reliability Study
NCT04677426 ·Status: WITHDRAWN ·Phase: PHASE2
-
The Role of Quantitative CT and Radiomic Biomarkers for Precision Medicine in Pulmonary Fibrosis
NCT06323876 ·Status: RECRUITING
-
Longitudinal Follow up to Assess Biomarkers Predictive of Emphysema Progression in Patients With COPD (Chronic Obstructive Pulmonary Disease)
NCT02719184 ·Status: COMPLETED
-
COPD Exacerbation Blood and Urine Biomarkers Study
NCT03823443 ·Status: TERMINATED
-
Genentech Xenon MRI Idiopathic Pulmonary Fibrosis
NCT04071769 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Diagnostic Value of Ultralow-dose Computed Tomography for the Detection of Pulmonary Nodules and Lung Parenchym Alterations Compared to Standard-dose CT
NCT02468609 ·Status: UNKNOWN ·Phase: NA
-
Community Acquired Pneumonia in Older Adults
NCT04709978 ·Status: COMPLETED
-
Characterization of Apolipoprotein A-I Pathways in Idiopathic Pulmonary Fibrosis
NCT02315586 ·Status: COMPLETED
-
Photon-counting CT in Chest Imaging
NCT07031336 ·Status: RECRUITING ·Phase: NA
-
Analyzing Lung Tissue in People With and Without Chronic Obstructive Pulmonary Disease Who Are Undergoing Lung Transplantation
NCT00756522 ·Status: COMPLETED
-
Integrated Radiographic and Metabolomics Risk Assessment in Patients With Interstitial Lung Diseases
NCT04119115 ·Status: TERMINATED
-
Effects of Bronchodilation on Computed Tomography (CT) Parameters Reflecting Airways Remodelling, and Pulmonary Emphysema Extent.
NCT01142531 ·Status: COMPLETED
-
Genentech Validation Tool for Pulmonary Fibrosis
NCT04676594 ·Status: ACTIVE_NOT_RECRUITING
-
Czech AATD Registry
NCT05178277 ·Status: RECRUITING
-
Magnetic Resonance Lung Function Imaging Study of Pulmonary Fibrosis Combined With Emphysema Syndrome
NCT06431555 ·Status: RECRUITING
-
Assessment of Lung Movement With Computed Tomography (CT)
NCT03068091 ·Status: COMPLETED ·Phase: NA